What Is Carcinomatous Lymphangitis?

Lymphangitis is most commonly caused by bacterial infection entering through a local wound or ulcer; however, in some patients, no definite portal of bacterial entry is identified, and the infection spreads via lymphatic vessels to regional lymph nodes. Severe cases are often accompanied by fever, headache, generalized malaise, anorexia, and leukocytosis—making early treatment critical. So, what is carcinomatous lymphangitis? The following section addresses this question.

What Is Carcinomatous Lymphangitis?

Carcinomatous lymphangitis is a distinctive clinical manifestation of pulmonary metastasis arising from primary tumors both within and outside the lung. It results from tumor cells proliferating along and infiltrating lymphatic vessels, filling them with malignant cells and inducing perilymphatic fibroblastic proliferation. Lesions typically spread centrifugally from the hilum toward the lung periphery. Patients primarily present with dyspnea, cough, and tachypnea. Radiologically, findings include reticular nodular opacities and bronchial wall thickening. On CT, characteristic features include beaded, interlobular septal thickening.

Treatment of Lymphangitis

1. General Measures: Except during the acute phase or in cases of severe inflammation, patients are generally encouraged to remain active. Preventive measures against tinea pedis (athlete’s foot) and filariasis infections should be routinely practiced; if such infections occur, prompt treatment is essential.

2. Pharmacologic Therapy: Antibiotics are administered to control infection; traditional Chinese medicine may also be used as adjunctive therapy.

3. Local Management: Local warm compresses and limb elevation help promote venous and lymphatic return. To prevent lymphedema, compression bandaging of the affected limb is applied to impede lymphatic stasis. If a localized infection progresses to abscess formation, timely incision and drainage are required.

We hope the above information is helpful to you.